Heron Therapeutics, Inc.HRTXNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank86
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-17.88M
↑ 88% vs avg
Percentile
P86
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-147.85M
Historical baseline
PeriodValueYoY Change
2025$-17.88M-253.7%
2024$-5.06M+95.1%
2023$-103.79M+41.2%
2022$-176.66M+17.9%
2021$-215.25M+3.3%
2020$-222.53M-10.6%
2019$-201.23M-15.2%
2018$-174.66M+9.0%
2017$-192.02M-13.4%
2016$-169.38M-